Citizens Financial Group Inc. RI Increases Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Citizens Financial Group Inc. RI lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 20.9% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 8,120 shares of the medical equipment provider’s stock after purchasing an additional 1,406 shares during the quarter. Citizens Financial Group Inc. RI’s holdings in Intuitive Surgical were worth $3,989,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in ISRG. Moran Wealth Management LLC lifted its stake in Intuitive Surgical by 24.2% during the 3rd quarter. Moran Wealth Management LLC now owns 1,749 shares of the medical equipment provider’s stock worth $859,000 after acquiring an additional 341 shares in the last quarter. Portfolio Design Labs LLC boosted its stake in shares of Intuitive Surgical by 479.7% in the third quarter. Portfolio Design Labs LLC now owns 3,519 shares of the medical equipment provider’s stock valued at $1,729,000 after purchasing an additional 2,912 shares during the period. First Horizon Advisors Inc. grew its holdings in shares of Intuitive Surgical by 5.0% in the third quarter. First Horizon Advisors Inc. now owns 6,707 shares of the medical equipment provider’s stock valued at $3,295,000 after purchasing an additional 318 shares in the last quarter. Advisors Asset Management Inc. increased its stake in Intuitive Surgical by 18.9% during the 3rd quarter. Advisors Asset Management Inc. now owns 14,240 shares of the medical equipment provider’s stock worth $6,996,000 after buying an additional 2,265 shares during the period. Finally, Connor Clark & Lunn Investment Management Ltd. acquired a new stake in Intuitive Surgical during the 3rd quarter worth approximately $11,356,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, insider Jamie Samath sold 269 shares of the firm’s stock in a transaction on Monday, November 11th. The stock was sold at an average price of $539.89, for a total value of $145,230.41. Following the completion of the sale, the insider now owns 8,757 shares of the company’s stock, valued at approximately $4,727,816.73. This trade represents a 2.98 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Mark Brosius sold 2,128 shares of the company’s stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the transaction, the senior vice president now directly owns 273 shares in the company, valued at approximately $140,595. This trade represents a 88.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 50,935 shares of company stock worth $26,305,169 in the last three months. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $550.43 on Friday. Intuitive Surgical, Inc. has a one year low of $304.50 and a one year high of $551.78. The stock has a market capitalization of $196.05 billion, a price-to-earnings ratio of 88.49, a PEG ratio of 5.30 and a beta of 1.39. The company has a 50-day simple moving average of $503.57 and a 200-day simple moving average of $461.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. As a group, research analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on ISRG shares. Stifel Nicolaus upped their price objective on Intuitive Surgical from $475.00 to $525.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Robert W. Baird upped their price target on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a report on Thursday, October 17th. Wells Fargo & Company increased their price target on Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a research report on Friday, October 18th. Mizuho boosted their price objective on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Finally, JPMorgan Chase & Co. raised their target price on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a report on Friday, October 11th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $524.61.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.